CN101525620B - COPPOCK cataract disease-causing gene and detecting method thereof - Google Patents

COPPOCK cataract disease-causing gene and detecting method thereof Download PDF

Info

Publication number
CN101525620B
CN101525620B CN2009101315741A CN200910131574A CN101525620B CN 101525620 B CN101525620 B CN 101525620B CN 2009101315741 A CN2009101315741 A CN 2009101315741A CN 200910131574 A CN200910131574 A CN 200910131574A CN 101525620 B CN101525620 B CN 101525620B
Authority
CN
China
Prior art keywords
cataract
gene
ala
leu
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009101315741A
Other languages
Chinese (zh)
Other versions
CN101525620A (en
Inventor
张璐
刘平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbin Engineering University
Harbin Medical University
Original Assignee
Harbin Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbin Medical University filed Critical Harbin Medical University
Priority to CN2009101315741A priority Critical patent/CN101525620B/en
Publication of CN101525620A publication Critical patent/CN101525620A/en
Application granted granted Critical
Publication of CN101525620B publication Critical patent/CN101525620B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a COPPOCK cataract (granular nuclear cataract) disease-causing gene GJA3, and a G->A point mutation exists on the 427th basic group of a first exon of GJA3 gene of the COPPOCK cataract (granular nuclear cataract) patient. The invention also relates to the application of the mutant gene in the detection of diseases. The method provided by the invention can accurately diagnosticate congenital COPPOCK cataract (granular nuclear cataract) and distinguish the congenital COPPOCK cataract (granular nuclear cataract) from other congenital cataracts.

Description

COPPOCK cataract Disease-causing gene and detection method thereof
Technical field
What the present invention relates to is a kind of human variation's gene, specifically a kind of COPPOCK cataract Disease-causing gene GJA3.The invention still further relates to the application of this mutant gene in detecting disease.
Background technology
Congenital cataract (congenital cataract is that a kind of common eye is unusual CC), can cause tangible visual disorder or children blind, account for world children blind 1/10.Congenital cataract can isolate generation, can merge other eye heteroplasia, or the part of heredity multisystem syndromes.Approximately the congenital cataract of 1/3-1/4 is genetic, and the chain three kinds of modes of inheritance of autosomal dominant, autosomal recessive and X-all have report.Heredity congenital cataract is autosomal dominant mostly, and almost completely outer apparent still expressivity has nothing in common with each other.Although congenital cataract is the blind major causes of world children, its hereditary basis and pathogenesis are still not fully aware of.Location to the congenital cataract Disease-causing gene is an important step of understanding the molecular mechanism of its morbidity with the clone.
In recent years, along with the fast development of Protocols in Molecular Biology and information biology, increasing congenital cataract Disease-causing gene is positioned and clones.Up to now, individual surplus clear and definite localized site has 30 to autosomal dominant inheritance congenital cataract, individual surplus the Disease-causing gene that has found has 20.The Disease-causing gene of congenital cataract can be divided into 5 classes at present: (1) crystal protein gene comprises CRYAA, CRYAB, CRYBB1, CRYBB2, CRYBB3, CRYBA1/A3, CRYBA4, CRYGC, CRYGD, and CRYGS.(2) membrane protein gene comprises MIP, and LIM2. (3) slit connects protein gene, comprises GJA8, GJA3.(4) the cytoskeletal protein gene comprises BFSP1, BFSP2.(5) grow the regulatory factor gene, comprise PITX3, MAF, HSF4, FOXE3, EYA1, CHX10 and PAX6 etc.
Chinese patent application 200710144506.X discloses the relation of CRYGC genovariation and congenital nuclear cataract, the point mutation of a G->A of CRYGC gene the 3rd exon the 470th base, the codon of the 157th tryptophane that cause encoding has become terminator codon (W157X).And determine that this point mutation is the Disease-causing gene sudden change of congenital nuclear cataract.
Have many types because indication is detected in the clinical symptom of congenital cataract and laboratory, and studies show that, the different Clinical types transgenation with different respectively is relevant.Even same gene, the site difference of point mutation causes the symptom of congenital cataract just possible different thus.Therefore be necessary cataractous various Clinical types, especially also the Clinical types that does not have to find relevant molecular genetics basis is studied, to determine its accurate mutant gene title and site, and set up easily and fast and accurate test method according to this variation, be used for the diagnosis of congenital cataract.
Summary of the invention
The object of the present invention is to provide the COPPOCK cataract, be also referred to as the cataractous Disease-causing gene of nuclearity particulate state, orient the gene mutation site of this disease, and utilize this transgenation, the method that whether has this transgenation in the human body is provided.
The present invention is directed to a COPPOCK cataract family, Disease-causing gene is carried out chromosomal localization and candidate gene sudden change detection with the method for genescan and linkage analysis.After having got rid of the relevant chromosomal region of most of congenital cataract, with the Disease-causing gene Primary Location in No. 13 karyomit(e).Through accurately locating, Disease-causing gene is positioned karyomit(e) 13q11-12.Find a new point mutation by candidate gene GJA3 Gene Double to order-checking to congenital cataract in this locating area.By the normal member of family and 100 normal control GJA3 gene sequencing are not found this sudden change, single nucleotide polymorphisms (single nucleotide polymorphism, possibility SNP) have been got rid of.Thereby determine that the GJA3 transgenation is the cataractous Disease-causing gene sudden change of COPPOCK.Thus,
The invention provides a kind of human GJA3 gene of the variation shown in SEQ ID NO:1, it is characterized in that, the G of described GJA3 gene the 1st exon the 427th bit base sports A.Normal human GJA3 gene is shown in SEQ ID NO:2.
The present invention also provides a kind of above-mentioned Nucleotide of stating gene mutations that contains, and it is characterized in that, described Nucleotide contains from point mutation and extends more than 50 Nucleotide to length between 1000 bases at least to both sides or a side.
The present invention further provides described Nucleotide, it is characterized in that, described Nucleotide contains from point mutation and extends the Nucleotide of length between each and every one base of 300-600 at least to both sides or a side.
Whether deposit the method for described gene mutations in the biological specimen that the present invention also provides a kind of detection to derive from human body, it comprises step:
(1) from described sample, extracts and the purified genes material;
(2) described genetic material is carried out the polymerase chain amplified reaction, obtain product;
(3) described product is carried out nucleotide sequencing, to determine whether contain the GJA3 gene mutations in the described biological specimen.
Preferably, described biological specimen is a body fluid, and described body fluid includes but not limited to: blood, serum, amniotic fluid, lymph liquid etc.
Preferably described body fluid is blood.
Preferably, the primer that uses at described polymerase chain amplified reaction is to being: SEQ ID NO:6 and 7; Those skilled in the art can also design more kinds of primers according to the requirement of polymerase chain amplified reaction, to amplify the nucleotide sequence that comprises variant sites of the present invention.
The present invention also provides the application of above-mentioned Nucleotide in preparation congenital cataract disease gene diagnosing chip.Whether those skilled in the art are gene probe with this Nucleotide, according to the principle of gene recombination, can exist and this probe sequence complementary nucleotide sequence in the detection of biological sample.Therefore make also to detect whether exist gene mutation site of the present invention in the sample in this way.
Whether have the above-mentioned method of stating transgenation in the biological specimen that the present invention also provides a kind of detection to derive from human body, it comprises step:
(1) from described sample, extracts and the purified genes material;
(2) each described Nucleotide of genetic material and claim 1-3 that step (1) is obtained contacts.
(3) observe through step (2), whether described genetic material exists based on sequence-specific hybridization with described Nucleotide combines.
Preferably, described biological specimen is a blood.
Site according to GJA3 gene order variation provided by the invention, use the method for whether depositing described gene mutations in the biological specimen that detection provided by the invention derives from human body, a congenital COPPOCK cataract (nuclearity particulate state cataract) the normal Han nationality of family individuality is detected.The result shows that all cataract patients of family all have identical point mutation, and interior all the other normal individuals of family and 100 normal controls all do not have this sudden change.Prove that method provided by the invention can accurately diagnose congenital COPPOCK cataract (nuclearity particulate state cataract), and can distinguish mutually with other congenital cataract.
Description of drawings
Fig. 1 is mutant nucleotide sequence SEQ ID NO:1 and the normal sequence SEQ ID NO:2 contrast synoptic diagram in the mutational site.
Embodiment
Below in conjunction with embodiment the present invention is made a more detailed description; but following description only is used for the explanation of making an explanation property of the present invention; protection scope of the present invention is not carried out any restriction, protection scope of the present invention only is as the criterion with claims restricted portion.
The location of embodiment 1:GJA3 genovariation
(1) extraction of genomic dna: use the QIAGEN QIAamp DNA Blood Mini Kit of company test kit extracting blood sample genomic dna.
(2) genescan: divide preliminary scanning and two steps of fine scanning to carry out.At first the candidate region of having reported is tentatively scanned, in positive region, carried out fine scanning afterwards.
1, microsatellite marker: preliminary scanning uses genetic marker from Linkage mapping set version 2.5 (U.S. Applied Biosystems company); Fine scanning is selected from the Marshfield website with fluorescent marker, and sequence and relevant information are from the NCBI website, and be synthetic by American I nvitrogen company, 5 ' end FAM fluorescent mark.
2, multiplex PCR amplification: 5 μ L PCR reaction systems comprise: template DNA 1 μ L, 10 * PCR buffer0.5 μ L, dNTP 0.8 μ L, Mg 2+0.3 μ L, primer (forward and reverse 10pmol/ μ L) 0.05 μ L, HotStar TaqDNA polysaccharase 0.06 μ L, remaining volume is supplied by the sterilization distilled water.The PCR reaction conditions adopts " Touchdown " mode: pre-94 ℃ of sex change 30sec of sex change, the renaturation temperature is since 64 ℃, whenever carry out a thermal cycling renaturation temperature reduction and reduce to 57 ℃ for 0.5 ℃ always, the time of renaturation is 1min in the thermal cycling, extend to constant 72 ℃ of following 1.5min, 14 thermal cyclings altogether of this process.Through after this condition, reaction enters second and takes turns the promptly constant amplification phase.The renaturation temperature is set at 56 ℃, and other condition is constant, carries out 30 thermal cyclings.
3, gene type
PCR product 1 μ l mixes 95 ℃ of sex change 5min, ice baths immediately with MegaBACE1000TM ET400-R Size (diluting with 27: 100 with deionized water) 6 μ l.Go up electrophoresis 1h at MegaBACE1000 DNA analysis instrument (Britain AmershamPharmacia Biotech company), through software scans and collect graphic information, and, obtain the gene type data by GeneticProfiler 2.1 software analysis.
4, linkage analysis
After the gene type result manually proofreaded, adopt the Mlink linkage analysis software in the Linkage v5.1 software package to carry out the point-to-point transmission linkage analysis.Be 0.00,0.10,0.20,0.30 at recombination fraction (θ) respectively, 0.40 and calculated the score of logarithm advantage (log odds score, LOD) value at 0.50 o'clock.Judging criterion as a result: LOD value>1 is chain for prompting, and>2 is chain for supporting,>3 for chain certainly, and<-2 for negating chain.
(3) Fine Mapping
Near the positive region that obtains, selected more meticulous microsatellite marker.Genetic marker selects to come from marshfield and ncbi website.One 5 ' end was with FAM (blueness) fluorochrome label therein when the every pair of primer was synthetic, and the gene type of PCR condition, mark and the method for linkage analysis are all the same.
(4) haplotyping
Utilize Cyrillic software to produce a family collection of illustrative plates, can show the somatotype information of a plurality of genetic markers of each member in the collection of illustrative plates.Carrying out manual regulation for genetic affinity can arrange out each individual haplotype up and down to these information bases.According to the situation that haplotype is shared, can find the generation that exchanges and then the zone of one section minimum that can obtain finally sharing by all patients in individual patients.The zone of one section minimum that all patients of this section share promptly is the locating area of this family Disease-causing gene on karyomit(e).
By above-mentioned steps with the CRYAA assignment of genes gene mapping in being positioned at chromosomal 13q11-12 No. 13.
The chromosomal localization technology of gene is known technology in the molecular genetics field to those skilled in the art, and the present invention utilizes these known technology to remove to find to bring the mutant gene of disease to the mankind
Embodiment 2: the order-checking of mutant gene
(1) uses the QIAGEN QIAamp DNA Blood Mini Kit of company test kit extracting blood sample genomic dna;
(2) the sample DNA target fragment is carried out the PCR amplification in vitro, purpose is first exon (shown in the SEQ IN NO:1) that amplifies GJA3, shared 4 pairs of primer amplification first exons (table 1), the PCR reaction system is as shown in table 2, and the PCR response procedures is as shown in table 3.
Table 1COPPOCK cataract family GJA3 gene extron 1 sequencing primer
Figure G2009101315741D00051
Table 2PCR reaction system
Figure G2009101315741D00061
PCR is reflected on the 9700PCR instrument and carries out.
Table 3:PCR response procedures
Figure G2009101315741D00062
PCR product electrophoresis detection
PCR reaction is got 2 * Loading Buffer that 2 μ l reaction product add 2 μ l after finishing, centrifugal 30 seconds of 4000rpm, last sample in 1.5% sepharose, electrophoresis 15min under the 100V voltage, gel video camera shot detection;
(3) the PCR product is carried out purifying
Adopt SAP (arctic shrimp alkaline phosphatase) the remaining dNTP that degrades, Exo (exonuclease) the remaining primer of degrading is pre-mixed the back with SAP and two kinds of enzymes of Exo and 10 * damping fluid and preserves, and contains each 0.5 unit of SAP and EXO in every microlitre mixed solution,
For each purification reaction, get PCR product 1.5-2 μ l and add SAP enzyme 1.5 μ l,
Response procedures is: SAP/Exo handled the PCR product 40 minutes at 37 ℃, and then 85 ℃ continue 20 minutes deactivation SAP/Exo enzymes, 4 ℃ of insulations then;
(4) the PCR product is checked order
The sequencing reaction system is 5 μ l, comprises the PCR product behind the purifying, sequencing primer 3.2pmol and BDT (BigDye Terminator 3.1, Applied Biosystems).0.5 μ l, remaining volume ddH 2The O polishing,
The sequencing reaction program is as shown in table 4:
Table 4 sequencing reaction program
Figure G2009101315741D00071
After sequencing reaction finishes, need to remove the small-molecule substance that sequencing reaction brings, avoid its interference to the product purifying (order-checking back purifying) once more that checks order to order-checking.Purification step is as follows:
1) every hole adds 25 μ l sodium-acetates, one ethanolic soln (3M sodium-acetate+100% ethanol, volume ratio are 1: 25) in 96 orifice plates of sequencing reaction;
4 ℃, centrifugal 45 minutes of 4000rpm; Be inverted, 600rpm dried in centrifugal 1 minute.
2) add 50 μ l, 70% ethanolic soln again; 4 ℃, centrifugal 10 minutes of 4000rpm; Be inverted 600rpm dried in centrifugal 1 minute; Repeat once.
3) room temperature leaves standstill and allows approximately its seasoning half an hour.Before order-checking, to make the sex change of DNA sample earlier.The method of sex change is to add 10 μ l HiDi (deionized formamide) in the sample behind purifying, and 95 ℃ keep making it in 5 minutes complete sex change on the PCR instrument.At once put into ice after the sex change and prevented its renaturation at least in 2 minutes.Then going up sample to ABI PRISM 3100 sequenators/somatotype instrument (Applied Biosystems) checks order.
(5) sequencing result analysis
Using SEQUENCE ANALYSIS software analyzes sequencing result.The blast program of application ncbi database ( Http:// www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi), mutant nucleotide sequence and the genome sequence of finding compared, sequencing result is compared.After getting rid of the possibility of SNP, all members of family and 100 normal controls are checked order, judge sudden change whether with family be divided into from.
Carry out pcr amplification by 4 pairs of primers shown in the table 1, show through sequencing analysis product, the 427th base of the 1st exon generation G->A point mutation of the present invention is positioned at the amplification scope of the 2nd pair of primer (being shown in SEQ ID NO:6 and 7), therefore, this can be used for detection to the transgenation of congenital COPPOCK cataract (nuclearity particulate state cataract) Disease-causing gene GJA3 to primer.
Embodiment 3: a congenital COPPOCK cataract family is carried out the detection of GJA3 genovariation
In order to verify effect of the present invention, we collect a congenital COPPOCK cataract family of Heilongjiang Province.General physical checkup is visited or done in family member to get rid of other eye disease and system exception through investigation.Family member is carried out detailed eye examination, comprised the fundoscopy behind eyesight, slit-lamp microscope, the mydriasis.To confirm the cataract type, take pictures, the cataract phenotype of record patient by slit-lamp microscope through the ophthalmology slit lamp examination for all patients.All are participated in investigation and are all understood the purpose and meaning of this research and signed Informed Consent Form by the family member of blood sample collection.This family is totally 4 generations, 150 family members, wherein male 78 people, women 72 people.Extract volunteer's peripheric venous blood 5ml, after doing anti-freezing and handle with EDTA ,-20 ℃ of refrigerators are preserved.Gather individual 100 people of normal Han nationality in addition, gather peripheric venous blood 5ml, the EDTA anti-freezing ,-20 ℃ of refrigerators are preserved group in contrast.The sequencing result of 100 normal controls and family normal people's sequencing result is in full accord.
Two-way sequencing result shows GJA3 gene the 1st exon the 427th base of congenital COPPOCK cataract family, the point mutation that a G->A is arranged is (shown in SEQ ID NO:1, the normal sequence of SEQ ID NO:2 for not morphing, see shown in Fig. 1 rectangular box), cause the 143rd glycine password GGG of polypeptid coding sequence to become arginine password AGG (G->R, perhaps Gly->Arg) (shown in SEQ ID NO:3, see shown in two solid lines of Fig. 1).All cataract patients of family all have identical point mutation, and interior all the other normal individuals of family and 100 normal controls all do not have this sudden change.Thereby having got rid of it is the possibility of rare SNP.Determine that the GJA3 transgenation is the Disease-causing gene sudden change of this family.
KLPI090072-2009-4-3
Sequence table
<110〉Harbin Medical University
<120〉COPPOCK cataract Disease-causing gene and detection method thereof
<130>
<160>11
<170>PatentIn?version?3.3
<210>1
<211>1308
<212>DNA
<213>Homo?sapiens
<400>1
atgggcgact?ggagctttct?gggaagactc?ttagaaaatg?cacaggagca?ctccacggtc 60
atcggcaagg?tttggctgac?cgtgctgttc?atcttccgca?tcttggtgct?gggggccgcg 120
gcggaggacg?tgtggggcga?tgagcagtca?gacttcacct?gcaacaccca?gcagccgggc 180
tgcgagaacg?tctgctacga?cagggccttc?cccatctccc?acatccgctt?ctgggcgctg 240
cagatcatct?tcgtgtccac?gcccaccctc?atctacctgg?gccacgtgct?gcacatcgtg 300
cgcatggaag?agaagaagaa?agagagggag?gaggaggagc?agctgaagag?agagagcccc 360
agccccaagg?agccaccgca?ggacaatccc?tcgtcgcggg?acgaccgcgg?cagggtgcgc 420
atggccaggg?cgctgctgcg?gacctacgtc?ttcaacatca?tcttcaagac?gctgttcgag 480
gtgggcttca?tcgccggcca?gtactttctg?tacggcttcg?agctgaagcc?gctctaccgc 540
tgcgaccgct?ggccctgccc?caacacggtg?gactgcttca?tctccaggcc?cacggagaag 600
accatcttca?tcatcttcat?gctggcggtg?gcctgcgcgt?ccctgctgct?caacatgctg 660
gagatctacc?acctgggctg?gaagaagctc?aagcagggcg?tgaccagccg?cctcggcccg 720
gacgcctccg?aggccccgct?ggggacagcc?gatcccccgc?ccctgccccc?cagctcccgg 780
ccgcccgccg?ttgccatcgg?gttcccaccc?tactatgcgc?acaccgctgc?gcccctggga 840
caggcccgcg?ccgtgggcta?ccccggggcc?ccgccaccag?ccgcggactt?caaactgcta 900
gccctgaccg?aggcgcgcgg?aaagggccag?tccgccaagc?tctacaacgg?ccaccaccac 960
ctgctgatga?ctgagcagaa?ctgggccaac?caggcggccg?agcggcagcc?cccggcgctc 1020
aaggcttacc?cggcagcgtc?cacgcctgca?gcccccagcc?ccgtcggcag?cagctccccg 1080
ccactcgcgc?acgaggctga?ggcgggcgcg?gcgcccctgc?tgctggatgg?gagcggcagc 1140
agtctggagg?ggagcgccct?ggcagggacc?cccgaggagg?aggagcaggc?cgtgaccacc 1200
gcggcccaga?tgcaccagcc?gcccttgccc?ctcggagacc?caggtcgggc?cagcaaggcc 1260
agcagggcca?gcagcgggcg?ggccagaccg?gaggacttgg?ccatctag 1308
<210>2
<211>1308
<212>DNA
<213>Homo?sapiens
<400>2
atgggcgact?ggagctttct?gggaagactc?ttagaaaatg?cacaggagca?ctccacggtc 60
atcggcaagg?tttggctgac?cgtgctgttc?atcttccgca?tcttggtgct?gggggccgcg 120
gcggaggacg?tgtggggcga?tgagcagtca?gacttcacct?gcaacaccca?gcagccgggc 180
tgcgagaacg?tctgctacga?cagggccttc?cccatctccc?acatccgctt?ctgggcgctg 240
cagatcatct?tcgtgtccac?gcccaccctc?atctacctgg?gccacgtgct?gcacatcgtg 300
cgcatggaag?agaagaagaa?agagagggag?gaggaggagc?agctgaagag?agagagcccc 360
agccccaagg?agccaccgca?ggacaatccc?tcgtcgcggg?acgaccgcgg?cagggtgcgc 420
atggccgggg?cgctgctgcg?gacctacgtc?ttcaacatca?tcttcaagac?gctgttcgag 480
gtgggcttca?tcgccggcca?gtactttctg?tacggcttcg?agctgaagcc?gctctaccgc 540
tgcgaccgct?ggccctgccc?caacacggtg?gactgcttca?tctccaggcc?cacggagaag 600
accatcttca?tcatcttcat?gctggcggtg?gcctgcgcgt?ccctgctgct?caacatgctg 660
gagatctacc?acctgggctg?gaagaagctc?aagcagggcg?tgaccagccg?cctcggcccg 720
gacgcctccg?aggccccgct?ggggacagcc?gatcccccgc?ccctgccccc?cagctcccgg 780
ccgcccgccg?ttgccatcgg?gttcccaccc?tactatgcgc?acaccgctgc?gcccctggga 840
caggcccgcg?ccgtgggcta?ccccggggcc?ccgccaccag?ccgcggactt?caaactgcta 900
gccctgaccg?aggcgcgcgg?aaagggccag?tccgccaagc?tctacaacgg?ccaccaccac 960
ctgctgatga?ctgagcagaa?ctgggccaac?caggcggccg?agcggcagcc?cccggcgctc 1020
aaggcttacc?cggcagcgtc?cacgcctgca?gcccccagcc?ccgtcggcag?cagctccccg 1080
ccactcgcgc?acgaggctga?ggcgggcgcg?gcgcccctgc?tgctggatgg?gagcggcagc 1140
agtctggagg?ggagcgccct?ggcagggacc?cccgaggagg?aggagcaggc?cgtgaccacc 1200
gcggcccaga?tgcaccagcc?gcccttgccc?ctcggagacc?caggtcgggc?cagcaaggcc 1260
agcagggcca?gcagcgggcg?ggccagaccg?gaggacttgg?ccatctag 1308
<210>3
<211>435
<212>PRT
<213>Homo?sapiens
<400>3
Met?Gly?Asp?Trp?Ser?Phe?Leu?Gly?Arg?Leu?Leu?Glu?Asn?Ala?Gln?Glu
1 5 10 15
His?Ser?Thr?Val?Ile?Gly?Lys?Val?Trp?Leu?Thr?Val?Leu?Phe?Ile?Phe
20 25 30
Arg?Ile?Leu?Val?Leu?Gly?Ala?Ala?Ala?Glu?Asp?Val?Trp?Gly?Asp?Glu
35 40 45
Gln?Ser?Asp?Phe?Thr?Cys?Asn?Thr?Gln?Gln?Pro?Gly?Cys?Glu?Asn?Val
50 55 60
Cys?Tyr?Asp?Arg?Ala?Phe?Pro?Ile?Ser?His?Ile?Arg?Phe?Trp?Ala?Leu
65 70 75 80
Gln?Ile?Ile?Phe?Val?Ser?Thr?Pro?Thr?Leu?Ile?Tyr?Leu?Gly?His?Val
85 90 95
Leu?His?Ile?Val?Arg?Met?Glu?Glu?Lys?Lys?Lys?Glu?Arg?Glu?Glu?Glu
100 105 110
Glu?Gln?Leu?Lys?Arg?Glu?Ser?Pro?Ser?Pro?Lys?Glu?Pro?Pro?Gln?Asp
115 120 125
Asn?Pro?Ser?Ser?Arg?Asp?Asp?Arg?Gly?Arg?Val?Arg?Met?Ala?Arg?Ala
130 135 140
Leu?Leu?Arg?Thr?Tyr?Val?Phe?Asn?Ile?Ile?Phe?Lys?Thr?Leu?Phe?Glu
145 150 155 160
Val?Gly?Phe?Ile?Ala?Gly?Gln?Tyr?Phe?Leu?Tyr?Gly?Phe?Glu?Leu?Lys
165 170 175
Pro?Leu?Tyr?Arg?Cys?Asp?Arg?Trp?Pro?Cys?Pro?Asn?Thr?Val?Asp?Cys
180 185 190
Phe?Ile?Ser?Arg?Pro?Thr?Glu?Lys?Thr?Ile?Phe?Ile?Ile?Phe?Met?Leu
195 200 205
Ala?Val?Ala?Cys?Ala?Ser?Leu?Leu?Leu?Asn?Met?Leu?Glu?Ile?Tyr?His
210 215 220
Leu?Gly?Trp?Lys?Lys?Leu?Lys?Gln?Gly?Val?Thr?Ser?Arg?Leu?Gly?Pro
225 230 235 240
Asp?Ala?Ser?Glu?Ala?Pro?Leu?Gly?Thr?Ala?Asp?Pro?Pro?Pro?Leu?Pro
245 250 255
Pro?Ser?Ser?Arg?Pro?Pro?Ala?Val?Ala?Ile?Gly?Phe?Pro?Pro?Tyr?Tyr
260 265 270
Ala?His?Thr?Ala?Ala?Pro?Leu?Gly?Gln?Ala?Arg?Ala?Val?Gly?Tyr?Pro
275 280 285
Gly?Ala?Pro?Pro?Pro?Ala?Ala?Asp?Phe?Lys?Leu?Leu?Ala?Leu?Thr?Glu
290 295 300
Ala?Arg?Gly?Lys?Gly?Gln?Ser?Ala?Lys?Leu?Tyr?Asn?Gly?His?His?His
305 310 315 320
Leu?Leu?Met?Thr?Glu?Gln?Asn?Trp?Ala?Asn?Gln?Ala?Ala?Glu?Arg?Gln
325 330 335
Pro?Pro?Ala?Leu?Lys?Ala?Tyr?Pro?Ala?Ala?Ser?Thr?Pro?Ala?Ala?Pro
340 345 350
Ser?Pro?Val?Gly?Ser?Ser?Ser?Pro?Pro?Leu?Ala?His?Glu?Ala?Glu?Ala
355 360 365
Gly?Ala?Ala?Pro?Leu?Leu?Leu?Asp?Gly?Ser?Gly?Ser?Ser?Leu?Glu?Gly
370 375 380
Ser?Ala?Leu?Ala?Gly?Thr?Pro?Glu?Glu?Glu?Glu?Gln?Ala?Val?Thr?Thr
385 390 395 400
Ala?Ala?Gln?Met?His?Gln?Pro?Pro?Leu?Pro?Leu?Gly?Asp?Pro?Gly?Arg
405 410 415
Ala?Ser?Lys?Ala?Ser?Arg?Ala?Ser?Ser?Gly?Arg?Ala?Arg?Pro?Glu?Asp
420 425 430
Leu?Ala?Ile
435
<210>4
<211>19
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>4
ccatcccagt?accatccag 19
<210>5
<211>20
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>5
tctcttcagc?tgctcctcct 20
<210>6
<211>20
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>6
agaacgtctg?ctacgacagg 20
<210>7
<211>20
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>7
cctgcttgag?cttcttccag 20
<210>8
<211>18
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>8
cgagctgaag?ccgctcta 18
<210>9
<211>18
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>9
ctgccgggta?agccttga 18
<210>10
<211>19
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>10
cgcggacttc?aaactgcta 19
<210>11
<211>21
<212>DNA
<213〉artificial sequence
<220>
<223〉primer
<400>11
tctatctgct?ggtgggaagt?g 21

Claims (2)

1. the human GJA3 gene of a variation, it is characterized in that: its nucleotides sequence is classified as shown in the SEQ ID NO:1.
2. the application of the human GJA3 gene of the described variation of claim 1 in preparation congenital cataract disease gene diagnosing chip.
CN2009101315741A 2009-04-07 2009-04-07 COPPOCK cataract disease-causing gene and detecting method thereof Active CN101525620B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009101315741A CN101525620B (en) 2009-04-07 2009-04-07 COPPOCK cataract disease-causing gene and detecting method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009101315741A CN101525620B (en) 2009-04-07 2009-04-07 COPPOCK cataract disease-causing gene and detecting method thereof

Publications (2)

Publication Number Publication Date
CN101525620A CN101525620A (en) 2009-09-09
CN101525620B true CN101525620B (en) 2011-05-25

Family

ID=41093691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009101315741A Active CN101525620B (en) 2009-04-07 2009-04-07 COPPOCK cataract disease-causing gene and detecting method thereof

Country Status (1)

Country Link
CN (1) CN101525620B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105603114A (en) * 2016-03-30 2016-05-25 山东省眼科研究所 Application of LIM2 gene in detecting congenital CCMC (cataract-microcornea syndrome)
CN110624114B (en) * 2018-06-25 2021-07-16 沈阳何氏眼产业集团有限公司 Application of CRYGD protein

Also Published As

Publication number Publication date
CN101525620A (en) 2009-09-09

Similar Documents

Publication Publication Date Title
Shimizu et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma
Passmore et al. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population
CN105400880B (en) Early diagnosis of acute myocardial infarction marker
Henderson et al. Biallelic mutation of protocadherin-21 (PCDH21) causes retinal degeneration in humans
CN109913482B (en) PIK3CA-I874R mutant gene and application thereof in auxiliary diagnosis of breast cancer
US7335469B2 (en) Methods for diagnosing Noonan syndrome
CN101525620B (en) COPPOCK cataract disease-causing gene and detecting method thereof
CN101525619A (en) Anterior pole cataract disease-causing gene and detecting method thereof
KR101051385B1 (en) Primer set for obesity gene amplification, reagent for amplifying obesity gene comprising same and use thereof
Fang et al. Novel GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism
CN108753945B (en) SNP (single nucleotide polymorphism) locus related to obesity and/or hypertriglyceridemia of Chinese children and application thereof
CN110029167A (en) ERBB2-G519V mutated gene and its application in Computer-aided Diagnosis of Breast Cancer
CN103045722B (en) Detection kit of disease-causing gene CRYGD of crystalline congenital cataract
Endreffy et al. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families
CN110592198B (en) Method, system and kit for detecting FLT3/D835Y gene mutation with high sensitivity
TW202214874A (en) Rapid method for genotyping sting variants in human individuals
Paton et al. Molecular changes in the D-bifunctional protein cDNA sequence in Australasian patients belonging to the bifunctional protein complementation group
Zorai et al. Frequency and spectrum of hemochromatosis mutations in Tunisia
JP3886901B2 (en) Method for detecting mutant gene dspp in hereditary milky white elephant
JP4657857B2 (en) Diagnosis and prevention of metabolic syndrome
CN110452987A (en) One group of adenocarcinoma of lung diagnostic flag and its application
CA2528692C (en) Mutations in the slc40a1 gene associated to impaired iron homeostasis
EP1199372A2 (en) Polymorphisms in the human P2X7 gene
CN117487906B (en) GAMT gene mutant, reagent, kit and application
CN112940099B (en) RhD-T163P mutant and detection thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant